|
US7615368B1
(en)
|
1994-06-17 |
2009-11-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarrays of polypeptides
|
|
JP2002542487A
(en)
*
|
1999-04-15 |
2002-12-10 |
ザ、ボード、オブ、トラスティーズ、オブ、ザ、リーランド、スタンフォード、ジュニア、ユニバーシティ |
Polypeptide microarray
|
|
EP1158058A1
(en)
*
|
2000-05-19 |
2001-11-28 |
Centre National De La Recherche Scientifique |
Compositions and methods suitable for nucleic acid analyses
|
|
AU2002308128A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universitat Tubingen In Reutlingen Sti |
Method for determining analyte molecules in a sample
|
|
DK1502102T3
(en)
*
|
2002-03-11 |
2009-05-04 |
Caprotec Bioanalytics Gmbh |
Compounds and Methods for Analyzing the Proteome
|
|
WO2004064972A2
(en)
|
2003-01-16 |
2004-08-05 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
|
KR100690948B1
(en)
|
2004-06-17 |
2007-03-09 |
한국과학기술원 |
Microbial surface expression method of target protein using outer membrane protein of E. coli
|
|
KR100784261B1
(en)
|
2006-01-02 |
2007-12-11 |
한국과학기술원 |
Microbial surface expression method of target protein using spore envelope membrane protein of anthrax
|
|
EP2408905B1
(en)
|
2009-03-16 |
2017-05-10 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
|
|
ES2560674T3
(en)
|
2009-03-31 |
2016-02-22 |
Atyr Pharma, Inc. |
Compositions and procedures comprising aspartyl-tRNA synthetases with non-canonical biological activities
|
|
JP6066900B2
(en)
|
2010-04-26 |
2017-01-25 |
エータイアー ファーマ， インコーポレイテッド |
Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of cysteinyl tRNA synthetase
|
|
EP2563381B1
(en)
|
2010-04-27 |
2017-08-09 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
|
CA2800557A1
(en)
|
2010-04-29 |
2011-11-03 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy
|
|
US9034320B2
(en)
|
2010-04-29 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
|
|
CN103097523B
(en)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds
|
|
EP2566515B1
(en)
|
2010-05-03 |
2017-08-02 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
|
WO2011140132A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
|
|
CA2797978C
(en)
|
2010-05-03 |
2019-12-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
|
AU2011248101B2
(en)
|
2010-05-04 |
2016-10-20 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
|
|
AU2011252990B2
(en)
|
2010-05-14 |
2017-04-20 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
|
|
AU2011256366C1
(en)
|
2010-05-17 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
|
|
AU2011258106B2
(en)
|
2010-05-27 |
2017-02-23 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
|
CN103118694B
(en)
|
2010-06-01 |
2016-08-03 |
Atyr医药公司 |
The discovery for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of lysyl-tRNA synzyme
|
|
CA2804416C
(en)
|
2010-07-12 |
2020-04-28 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
|
WO2012027611A2
(en)
|
2010-08-25 |
2012-03-01 |
Atyr Pharma, Inc. |
INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
|
|
CN103930563B
(en)
|
2011-06-01 |
2016-11-09 |
医学预后研究所 |
For the method and apparatus predicting cancer return
|
|
CA2864300A1
(en)
|
2012-02-16 |
2013-08-22 |
Atyr Pharma, Inc. |
Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
|
|
WO2014085434A1
(en)
|
2012-11-27 |
2014-06-05 |
Pontificia Universidad Catolica De Chile |
Compositions and methods for diagnosing thyroid tumors
|
|
CN103245788B
(en)
*
|
2013-03-22 |
2015-01-21 |
赵树民 |
Peptide array synthesis technology for B cell antigen epitope screening
|
|
US10392667B2
(en)
|
2013-06-07 |
2019-08-27 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
|
|
EP3169815B1
(en)
|
2014-07-15 |
2020-12-23 |
Ontario Institute For Cancer Research |
Methods and devices for predicting anthracycline treatment efficacy
|
|
IL253180B2
(en)
|
2015-01-02 |
2023-04-01 |
Dyax Corp |
Bispecific antibodies against plasma kallikrein and factor xii
|
|
BR112018001202A2
(en)
|
2015-07-21 |
2018-09-25 |
Dyax Corp |
monoclonal antibody, nucleic acid, vector, host cell, pharmaceutical composition and method
|